SCHEMBL20190476

SCHEMBL20190476

COc1ccc(CNS(=O)(=O)[C@H](C)CCc2ncc(F)cn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
ALDH1A1 P00352 4/20 0.44
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TSHR P16473 2/20 0.43
GAA P10253 1/20 0.41
APLNR P35414 3/20 0.41
POLB P06746 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20167294 0.88 APLNR (0.50) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20168252 0.88 APLNR (0.50) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20167297 0.88 APLNR (0.50) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL18247235 0.81 LMNA (0.49) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20190021 0.80 LMNA (0.48) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20189566 0.80 LMNA (0.48) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20189568 0.80 LMNA (0.48) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20191069 0.79 LMNA (0.47) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20187774 0.79 LMNA (0.47) LMNAALDH1A1HTTSMN1; SMN2TSHR
SCHEMBL20189055 0.79 LMNA (0.47) LMNAALDH1A1HTTSMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541792-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR Amgen Inc. (US) 2019-09-25 EP disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 WO disclosed